Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression

• Published in: BMC pharmacology & toxicology Vol. 21; no. 1; p. 81
• Main Authors: Ali, Hassan, Khan, Ashrafullah, Ali, Jawad, Ullah, Hadayat, Khan, Adnan, Ali, Hussain, Irshad, Nadeem, Khan, Salman
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 25-11-2020; BioMed Central
• Subjects: Acids; Acute respiratory distress syndrome; Analysis; Antioxidants; Attenuation; Body temperature; Catalase; Cyclooxygenase-2; Cytokines; Dosage; Edema; Enzyme-linked immunosorbent assay; Ethics; Health aspects; Hematology; IL-1β; Immunohistochemistry; Inflammation; Injuries; Interaction parameters; Interleukin 6; Laboratory animals; Leukocytes (neutrophilic); Lipopolysaccharides; Lungs; Malondialdehyde; Markers; Mathematical models; Medical research; Medicine, Experimental; Molecular docking; Morbidity; Mortality; Neutrophils; Nitric oxide; Nitric-oxide synthase; NRF2 protein; Oxidants; Oxidative stress; Oxidizing agents; Permeability; Pharmacokinetics; Physicochemical properties; Proteins; Respiratory distress syndrome; Survival; Tumor necrosis factor; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Pakistan; St Louis Missouri; Islamabad Pakistan; United States > US; Antioxidants; Inflammation; Cytokines; Continentalic acid; LPS
• ISSN: 2050-6511; 2050-6511
• DOI: 10.1186/s40360-020-00458-7

Acute lung injury (ALI) together with acute respiratory distress syndrome (ARDS) are associated with high rate of mortality and morbidity in patients. In the current study, the anti-inflammatory effects of continentalic acid (CNT) in LPS-induced acute lung injury model was explored.
The acute lung injury model was established by administering LPS (5 mg/kg) intraperitonealy. Following LPS administration, the survival rate, temperature changes and lung Wet/Dry ratio were assessed. The antioxidants (GSH, GST, Catalase and SOD) and oxidative stress markers (MDA, NO, MPO) were evaluated in all the treated groups. Similarly, the cytokines such as IL-1β, IL-6 and TNF-α were analyzed using ELISA assay. The histological changes were determined using H and E staining, while Nrf2 and iNOS level were determined using immunohistochemistry analysis. The molecular docking analysis was performed to assess the pharmacokinetics parameters and interaction of the CNT with various protein targets.
The results showed that CNT dose dependently (10, 50 and 100 mg/kg) reduced mortality rate, body temperature and lungs Wet/Dry ratio. CNT post-treatment significantly inhibited LPS-induced production of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α. The CNT post-treatment markedly improved the hematological parameters, while significantly reduced the MPO (indicator of the neutrophilic infiltration) activity compared to the LPS treated group. Furthermore, the CNT (100 mg/kg) post-administration remarkably inhibited the lung Wet/Dry ratio. The CNT (100 mg/kg) treated group showed marked reduction in the oxidative stress markers such as malonaldehyde (MDA) and Nitric oxide (NO) concentration, while induced the level of the anti-oxidant enzymes such as GST, GSH, Catalase and SOD. Similarly, the CNT markedly reduced the iNOS expression level, while induced the Nrf2 protein expression. Additionally, the molecular docking study showed significant binding interaction with the Nrf2, p65, Keap1, HO-1, IL-1β, IL-6, TNF-α and COX-2, while exhibited excellent physicochemical properties.
The CNT showed marked protection against the LPS-induced lung injury and improved the behavioral, biochemical and histological parameters. Furthermore, the CNT showed significant interaction with several protein targets and exhibited better physicochemical properties.